| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 598.11B | 468.84B | 360.53B | 351.03B | 272.29B | 231.56B |
| Gross Profit | 41.37B | 34.11B | 29.15B | 32.57B | 29.29B | 23.78B |
| EBITDA | 20.25B | 15.57B | 11.84B | 16.13B | 14.91B | 10.18B |
| Net Income | 12.49B | 9.46B | 7.29B | 9.70B | 9.56B | 6.10B |
Balance Sheet | ||||||
| Total Assets | 206.33B | 168.90B | 148.94B | 129.21B | 115.80B | 104.27B |
| Cash, Cash Equivalents and Short-Term Investments | 11.37B | 12.88B | 14.57B | 11.76B | 11.38B | 8.80B |
| Total Debt | 53.27B | 33.47B | 29.40B | 19.24B | 16.39B | 17.30B |
| Total Liabilities | 101.04B | 68.76B | 57.56B | 44.56B | 41.37B | 38.66B |
| Stockholders Equity | 104.72B | 99.74B | 91.11B | 84.48B | 74.30B | 65.49B |
Cash Flow | ||||||
| Free Cash Flow | -17.91B | -1.06B | -4.70B | -492.00M | 4.84B | -3.28B |
| Operating Cash Flow | -14.09B | 2.54B | 1.83B | 10.65B | 7.03B | 185.00M |
| Investing Cash Flow | -5.24B | -6.24B | -7.96B | -12.19B | -2.52B | -3.18B |
| Financing Cash Flow | 16.14B | 210.00M | 8.08B | 1.38B | -2.26B | 261.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥96.79B | 14.20 | ― | 3.38% | 10.74% | -26.50% | |
78 Outperform | ¥47.49B | 5.27 | ― | 3.87% | 2.66% | -11.41% | |
73 Outperform | ¥315.78B | 21.53 | ― | 1.68% | 7.95% | 28.36% | |
73 Outperform | ¥55.23B | 13.47 | ― | 3.00% | 16.06% | 31.78% | |
67 Neutral | ¥159.21B | 6.77 | ― | 1.72% | 32.43% | 39.26% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥154.50B | 9.98 | ― | 2.42% | 9.74% | 6.48% |